Roger S. Goody studied Chemistry at the University of Birmingham, England, where he got his PhD in 1968. He then accepted a post-doctoral position at the Memorial Sloan-Kettering Cancer Center in New York City, NY, USA in the field of natural products research. In 1970 he became a scientific fellow at the Max Planck Institute for Experimental Medicine, Göttingen in the field of nucleotide research.
From 1972 till 1993 he was a group leader at the Max Planck Institute for Medical Research, Heidelberg in the field of enzymology and nucleotide research, with a focus on actin, myosin, adenylate kinase, EF-Tu, HRAS-p21, reverse transcriptase, nucleotides and nucleic acid sequencing. An overriding theme of his research interests has been the transient states of enzymes, along the enzyme reaction pathway, against the background of selective and specific ligand-protein interactions and structure-function relationships. In 1983 he habilitated at the faculty for biochemistry and biophysics of the University of Heidelberg and was announced adjunct professor in 1990. In 1993 he accepted the position of Director at the Max Planck Institute for Molecular Physiology, Dortmund and became a scientific fellow of the Max Planck Society. Since 2004 Roger Goody has also held a full professorship in biochemistry (supramolecular systems) at the Ruhr University Bochum, with a dual emphasis on higher education and fundamental research. Since 2013, Roger Goody is President of the German Society for Biochemistry and Molecular Biology (GBM). He is married and has two children.